Molecular Diagnostics firm Atonarp inks $33 mln Series C

Atonarp, a molecular diagnostics company, has raised $33 million in Series C funding. The investors included Japan Post Investment Corporation, SBI Investment Co., Ltd, Northwestern Mutual Future Ventures, INCJ Ltd and Innovative Venture Fund Investment Limited Partnership.

North AmericaUSHealthcareBriefs